499 related articles for article (PubMed ID: 27385363)
1. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of Graves' disease in patients with thyroid eye disease].
Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
[TBL] [Abstract][Full Text] [Related]
4. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
Douglas RS; Goldberg RA; Smith TJ
Thyroid; 2008 Sep; 18(9):931. PubMed ID: 18788916
[No Abstract] [Full Text] [Related]
5. Thyroid eye disease: a review.
Weiler DL
Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
[TBL] [Abstract][Full Text] [Related]
6. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Graves' Orbitopathy.
Panagiotou G; Perros P
Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
[TBL] [Abstract][Full Text] [Related]
8. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
9. Severe Pediatric Thyroid Eye Disease: Surgical Case Series.
Wu CY; Elner VM; Kahana A
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S186-S188. PubMed ID: 26524159
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of Graves' orbitopathy.
Lee HB; Rodgers IR; Woog JJ
Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
[TBL] [Abstract][Full Text] [Related]
11. Editorial: News in Graves' orbitopathy: patients management and treatments.
Lanzolla G; Sabini E
Front Endocrinol (Lausanne); 2023; 14():1270467. PubMed ID: 37664861
[No Abstract] [Full Text] [Related]
12. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
Yu CY; Ford RL; Wester ST; Shriver EM
Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
[TBL] [Abstract][Full Text] [Related]
13. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
[TBL] [Abstract][Full Text] [Related]
14. Management of patients in a combined thyroid eye clinic in secondary care.
Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine orbitopathy].
Mühl-Benninghaus R
Radiologie (Heidelb); 2024 Mar; 64(3):215-218. PubMed ID: 38321288
[TBL] [Abstract][Full Text] [Related]
16. Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy.
Bajkowska D; Szelachowska M; Buczyńska A; Krętowski AJ; Siewko K
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358969
[TBL] [Abstract][Full Text] [Related]
17. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
[TBL] [Abstract][Full Text] [Related]
18. Thyroid eye disease or Graves' orbitopathy: What name to use, and why it matters.
Wagner LH; Bradley EA; Tooley AA; Ren Y; Rachmasari KN; Stan MN
Front Endocrinol (Lausanne); 2022; 13():1083886. PubMed ID: 36518254
[TBL] [Abstract][Full Text] [Related]
19. Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence.
Nivean PD; Madhivanan N; Kumaramanikavel G; Berendschot TTJM; Webers CAB; Paridaens D
Hormones (Athens); 2024 Mar; 23(1):25-34. PubMed ID: 37910311
[TBL] [Abstract][Full Text] [Related]
20. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
